Top 10 Challenges: Pharmaceutical R & D of Lyophilized Drug Product

Introduction

Lyophilization, or freeze-drying, is a method of dehydrating a substance by sublimation and desorption, creating a dry and stable product. Lyophilization is commonly used in the pharmaceutical, biotechnology, and food industries, as it can maintain the quality, efficacy, and shelf-life of various products, such as vaccines, proteins, enzymes, and fruits. However, lyophilization is also a complicated and expensive method, which presents many challenges for R & D of Pharmaceutical Drug Product. This articles captures, Top 10 challenges of R & D Phase of Lyophilized Drug Products.

Challenges of Lyophilization: R & D Drug Product:

Challenge 1: Design and Formulations

Formulations affect the quality and stability of freeze-dried products, as they influence the product's physical and chemical features, such as glass transition temperature, collapse temperature, cake appearance, reconstitution time, and residual moisture.

To design and improve formulations, we need to know how the product and the excipients, like sugars, polymers, salts, and surfactants, interact, and how pH, concentration, and freezing rate influence the final drug product characteristics.

For Instance;

A) Applying the principles of quality by design (QbD) and design of experiments (DoE) to fine-tune the formulation and process variables, according to the target critical quality attributes (CQAs) and critical process parameters (CPPs) of the product. QbD and DoE can help lower the chance of failure, improve the effectiveness and reliability of the process, and facilitate smoother scale-up and technology transfer.

B) Using computational modeling and simulation methods to forecast and study how heat and mass are transferred, how the product temperature and moisture change, and how the process works during freeze-drying. Computational models can aid to plan and compare different situations, find the best operating conditions, and assist in making decisions and solving problems.

C) Using novel techniques and methods, like controlled nucleation, vacuum foam drying, spray freeze-drying, and microwave-assisted freeze-drying, to improve the quality, save time and energy, and solve some of the problems and difficulties of regular freeze-drying. Use different analytical methods, such as differential scanning calorimetry, freeze-drying microscopy, Fourier transform infrared spectroscopy, and X-ray diffraction, to study the product and the formulation. New techniques and methods can open up new possibilities for making lyophilized products with better features and functions.

Challenges 2: Cycle Development

Before lyophilization can be feasible, efficient, and robust, and the drug product must be consistent in quality, process development and scale-up. A robust Cycle development involve finding the best freezing, primary drying, and secondary drying conditions, and assessing how different process parameters, such as shelf temperature, chamber pressure, product load, and vial size and shape, affect the process.

Process development and scale-up also need various process analytical tools, such as thermocouples, manometric temperature measurement, tunable diode laser absorption spectroscopy, and near-infrared spectroscopy, to track and control the process. It can be accomplished by either or combination of following key approaches,

A)   Performing Design of Experiment based on changing one parameter at a time and keeping the rest fixed, and seeing how this affects the product's quality and look. This method is easy and direct, but it can take a lot of time and money, especially for complicated formulations or big processes.

 B) Predicting the best process conditions based on mathematical models that use the product's physical and chemical properties, like glass transition temperature, eutectic temperature, collapse temperature, and cake resistance. This method can save experiments and help understand the process mechanisms, but it can be difficult to verify and use for complex or multi-component formulations or systems.

C) Adopting a hybrid method that blends empirical and theoretical techniques, which entails using mathematical models to inform the experimental design and then using experimental data to adjust and enhance the models. This method can leverage the strengths and weaknesses of both techniques and produce more precise and dependable outcomes, but it can be difficult to combine and execute.

Challenge 3: Container and Closure system

The container and closure system affects the product's stability, integrity, and delivery, therefore, selection and testing of container closure system are important parts of lyophilization product research and development. This involves selection of right material, size, shape, and design for the container and the closure, and assessing its compatibility with the drug product constituents across its shelf life.

Most compatible container closure system for a drug product can be selected in following three stages;

A) Identifying the critical quality attributes (CQAs) of the product, such as potency, purity, sterility, pH, moisture content, and appearance, and defining the acceptance criteria for each CQA.

B) Screening and evaluating different types of containers and closures, such as vials, syringes, cartridges, stoppers, caps, and seals, based on their suitability for the product, the process, and the end-user. This includes testing their compatibility, functionality, performance, and integrity under various conditions, such as freezing, drying, reconstitution, and storage.

C) Selecting the optimal container closure system that meets the CQAs and the regulatory requirements, and validating its reliability, robustness, and reproducibility throughout the product lifecycle. This includes conducting stability studies, leachable and extractable studies, seal strength tests, and container closure integrity tests, and documenting the results and rationales

Challenge 4: Product Stability and Shelf-Life Prediction

To ensure the quality and safety of lyophilized products, it is important to predict its stability and product's shelf life. This comprises of investigating and measuring how the product degrades over time, such as by oxidation, deamidation, aggregation, and hydrolysis, and how different environment and the storage conditions; such as temperature, humidity, light, and oxygen affects the product degradation. It can be accomplished by analytical assessment of accelerated, ambient/real-time, and forced degradation stability samples at pre-determined intervals by high-performance liquid chromatography, size-exclusion chromatography, electrophoresis, and mass spectrometry.

The top three stages of assessing lyophilized product stability and shelf-life prediction are:

A) Accelerated stability studies: These studies put the product under extreme conditions than the normal storage conditions, like higher temperature, humidity, light, and oxygen. This makes the product degrade faster and lets us see how the product quality changes over time. These studies can give us an early idea of the product shelf-life and demonstrate the factors that affect the product stability. But these studies are not enough, as they may not show how the product really degrades under normal conditions.

B) Real-time stability studies: In this study, the products are stored under the recommended conditions, such as temperature, humidity, light, and oxygen, for a certain time, and analyzed for the product quality periodically. Real Time stability studies can provide a more accurate and reliable shelf-life estimate and confirm the accelerated stability studies. These studies are required for the regulatory approval and release of the product.

C) Forced degradation studies: In these stability studies define and store the in-process and finished drug products under extreme stress-stability conditions, such as high or low pH, high temperature, oxidation, and enzymatic degradation, to induce degradation and find the possible degradation routes and byproducts. These studies can help understand the product stability profile and develop and validate the methods for measuring the degradation products. Therefore, these studies can aid to design the formulation and the lyophilization cycle.

Challenge 5: Product Characterization and Quality Control

The lyophilized product needs to be verified and validated via physico-chemical characterization of the in-process and finished drug product and quality control, which ensure that the product meets the required specifications and standards, appearance, potency, assay, purity, safety, and identity, etc.

Product characterization and quality control use various analytical methods, such as visual inspection, moisture determination, reconstitution time measurement, residual gas analysis, particulate matter testing, assay, sterility testing, and endotoxin testing, to measure the product features and performance. Product characterization and quality control also apply various statistical tools, such as design of experiments, process capability analysis, and control charts, to evaluate the product variation and dependability. 

A)      Pre-Freeze-Drying Characterization

In this stage, the drug substance and the formulation are characterized before they are freeze-dried, for instance, the solution's solubility, stability, pH, viscosity, osmolality, etc. and to predict post-freezing characterizing. This stage is important to find out the best formulation composition, fill volume, and freezing conditions for the freeze-drying process.

B)      In-Process Characterization

This stage involves measuring the product's properties during the lyophilization, such as the rate of sublimation, heat transfer coefficient, product temperature, leftover moisture, cake resistance, and end of primary drying. This stage is important to check and adjust the process parameters, such as the pressure in the chamber and the temperature of the shelf, and to ensure the product quality and consistency.

C) Post-Lyophilization

This stage involves measuring the final product's properties after lyophilization, such as the look, time to reconstitute, potency, purity, identity, sterility, endotoxin, particulate matter, and moisture content of the product. This stage is important to confirm and verify that the product meets the required requirements and standards for storage, transportation, and use.

Challenge 6: Cycle Optimization and Robustness

Lyophilization product research and development aim to make the lyophilization process faster, cheaper, safer, and better in terms of product quality and consistency. This involves using different methods, such as mathematical modeling, simulation, optimization, and design space, to find and manage the key factors that affect the process and product. It can be accomplished using different strategies, such as controlled nucleation, adaptive feedback control, and quality by design, to improve the process efficiency and robustness. 

Some of the ways of cycle optimization and robustness are:

A) Controlled nucleation: This technique applies external methods, such as ice fog, gas injection, or ultrasound, to trigger the growth of ice crystals at a chosen temperature and pressure. This makes the ice structure more uniform and enhances the drying rate and product quality.

B) Adaptive feedback control: This technique adjusts the process parameters, such as chamber pressure, shelf temperature, and product temperature, using sensors and actuators that measure the product state in real time. This improves the process efficiency and robustness by reducing the impact of variations and disturbances.

C) Quality by Design: This technique applies a methodical approach to find and comprehend the key quality attributes and process parameters that influence the product quality and performance. It also uses a risk-based plan to set and improve the design space and the control strategy for the process. This guarantees the product quality and consistency by managing the variability sources.

 Challenge 7: Alternative Drying Technologies and Methods

Some of the drawbacks of conventional lyophilization (such as long time, high energy, and product variation), can be overcome by alternative drying technologies and methods. These alternatives use different techniques, such as microwave, radiofrequency, ultrasound, spray, and foam drying, to make the lyophilization process and product faster, more efficient, and more uniform. They also use different formats, such as microspheres, nanospheres, and films, to enhance the delivery and performance of the lyophilized product. 

Some of the ways of alternative drying technologies and methods are:

A)      Freeze-drying with microwaves, which uses electromagnetic waves to heat and remove the ice crystals in the frozen product, making the drying time shorter and the product quality better.

 B)      Freeze-drying with foam-mat, which involves creating a foam from the product and then freezing and drying it, making the product more porous and have a larger surface area and improving the drying rate and rehydration properties.

C)     Freeze-drying with spray, which involves making fine droplets from the product and then freezing and drying them, producing spherical particles with high stability and solubility. 

Challenge 8: Novel Formulation and Delivery Systems

Research and development of a lyophilized drug product can utilize novel formulation and delivery systems to improve the product's stability, solubility, bioavailability, and bioactivity, as well as make it easy, flexible, and compliant to use.

Novel formulation and delivery systems involve developing systems like liposomes, nanoparticles, micelles, and hydrogels, to hold, protect, and release the product; and designing systems like dual-chamber syringes, prefilled syringes, and needle-free injectors, to help with reconstituting and injecting the product. Some of the features of novel formulation and delivery systems are:

A)      Making the product more stable by preventing it from breaking down, clumping, rusting, or being affected by other factors in the environment.

B)      Ameliorating the product solubility and bioavailability, by chemical modification or altering the formulation the faster, pass through membranes easier, and absorb better.

Challenge 9: Regulatory Requirements and Guidelines

The research and development of lyophilization is influenced by the regulatory requirements and guidelines, which set the standards and rules for the approval and marketing of the lyophilized product. These involve following the regulations and guidelines of different authorities and agencies, such as the FDA, the EMA, and the ICH, on the quality, safety, and efficacy of the lyophilized product. They also include providing the documents and data, such as the CMC, the stability, and the bioequivalence, to support the lyophilization product development and registration. 

Some of the features of regulatory requirements and guidelines for lyophilized products are:

A) Ensure product quality, stability, and performance, regulatory bodies need a comprehensive knowledge of the lyophilization process and how it affects them. This involves performing suitable studies and tests, such as thermal analysis, moisture content, cake appearance, reconstitution time, and particle size distribution, to define and improve the lyophilization cycle and formulation.

B) To meet applicable regulators' requirements, the lyophilization process must be reliable and consistent across different scales, from the lab to the market. This requires using QbD and PAT principles to find and control the key factors and qualities of the process and product.

C) Regulatory guidelines require comprehensive and detailed documentation and communication of the freeze-drying product development and registration. This entails providing the appropriate information and data, such as the rationale, the development history, the criteria, the analytical methods, and the validation results, to justify and facilitate the freeze-drying product approval and marketing.

Challenge 10: Technology Transfer

To share and spread the information and experience from lyophilization product research and production, knowledge management and technology transfer are vital. They involve creating and keeping different systems and tools, such as databases, reports, and protocols, to collect, save, and access the knowledge and data about the lyophilization product and process. They also involve doing and recording various activities and steps, such as training, qualification, and validation, to move and use the lyophilization technology and know-how from the lab to the pilot and commercial scale.

Key Features and Steps: Technology Transfer in Lyophilized Drug Product:

A) Forming a cross-functional team that involves specialists from both the origin and destination sites, and external advisors if required. The team should keep in touch regularly and efficiently during the technology transfer process and address any problems or difficulties that emerge.

B) Creating a thorough and clear protocol and plan for transferring the product and process of lyophilization, including the ingredients, the steps, the tools, the testing methods, the quality features, and the standards. The protocol and plan should also define the tasks and duties of each stakeholder, schedules and goals, the paperwork and reporting needs, and the risk evaluation and prevention plans, etc.

C) Performing the activities and steps for transferring the technology as per the protocol and plan, such as the training, the qualification, the validation, the verification, and the problem-solving. The actions and procedures should be recorded and communicated in a transparent and coherent way, and any variations or modifications should be explained and authorized. The technology transfer should be assessed and confirmed by comparing the outputs and effects from the sending and receiving sites, and making sure that they satisfy the predetermined standards and requirements.

Conclusion

Lyophilization is an effective and adaptable method for preserving and delivering different products, especially biopharmaceuticals. However, lyophilization also presents many challenges towards development of Lyophilized Drug Product as it demands qualitative optimization of the combination of various disciplines, techniques, and tools. In this document, we have discussed the top 10 challenges in R & D of Lyophilized drug product development and the modes of addressing it. We hope that this document will act as a helpful resource and guide for the researchers, scientists, stakeholders of Lyophilized drug product.

References

1.  Wang, W. (2000). Lyophilization and development of solid protein pharmaceuticals. International journal of pharmaceutics, 203(1-2), 1-60.

2.  Nail, S. L., & Searles, J. A. (2008). Process analytical technology for freeze drying: the design space. In Freeze-drying/lyophilization of pharmaceutical and biological products (pp. 299-324). CRC Press.

3.  Roy, M. L., & Pikal, M. J. (2008). Process and product design issues in the development of freeze-dried parenteral products. In Freeze-drying/lyophilization of pharmaceutical and biological products (pp. 181-216). CRC Press.

4.  Shalaev, E. Y., & Franks, F. (1998). Solid-state chemistry of proteins: II. The correlation of storage stability of freeze-dried human growth hormone (hGH) with structure and dynamics in the glassy solid. Archives of biochemistry and biophysics, 360(1), 121-134.

5.  Searles, J. A., Carpenter, J. F., & Randolph, T. W. (2001). The ice nucleation temperature determines the primary drying rate of lyophilization for samples frozen on a temperature-controlled shelf. Journal of pharmaceutical sciences, 90(7), 860-871.

6.  Pisano, R., Fissore, D., & Barresi, A. A. (2014). Quality by design in the secondary drying stage of a freeze-drying process for protein formulations. Journal of pharmaceutical sciences, 103(5), 1405-1415.

 7.  Chakraborty, I., Das, S. K., & Das, A. R. (2014). Lyophilization process development for protein pharmaceuticals: a review. Journal of pharmaceutical education and research, 5(1), 41-54.

8.  Patel, S. M., & Patel, N. M. (2010). Recent advances in lyophilization and its future innovations. International Journal of Pharmaceutical Sciences Review and Research, 5(2), 29-35.

 9.  Patel, S. M., & Patel, N. M. (2010). Recent advances in lyophilization and its future innovations. International Journal of Pharmaceutical Sciences Review and Research, 5(2), 29-35.

 10.  Patel, S. M., & Patel, N. M. (2010). Recent advances in lyophilization and its future innovations. International Journal of Pharmaceutical Sciences Review and Research, 5(2), 29-35.

 11.  Nail SL, Jiang S. Lyophilization Technology in the 21st Century. In: Rey L, May JC, editors. Freeze-Drying/Lyophilization of Pharmaceutical & Biological Products. Third Edition. CRC Press; 2010. p. 1–39.

12.  Pikal MJ, Rambhatla S. Modeling in Lyophilization Process Development. In: Rey L, May JC, editors. Freeze-Drying/Lyophilization of Pharmaceutical & Biological Products. Third Edition. CRC Press; 2010. p. 165–198.

 13.  Tang XC, Nail SL. Hybrid Methods in Lyophilization Cycle Development. In: Rey L, May JC, editors. Freeze-Drying/Lyophilization of Pharmaceutical & Biological Products. Third Edition. CRC Press; 2010. p. 199–221.

 14.  Nail, S. L., & Akers, M. J. (2017). Fundamentals of freeze-drying. In Freeze-Drying/Lyophilization of Pharmaceutical and Biological Products (pp. 1-43). CRC Press.

15.  Kuu, W. Y., Nail, S. L., Sacha, G., & Nail, B. A. (2008). Quality by design: Lyophilization process development. Journal of pharmaceutical innovation, 3(3-4), 133-139.